Status:
RECRUITING
Flashed Light Therapy for Adolescents with ADHD and Delayed Sleep Timing
Lead Sponsor:
University of California, Los Angeles
Conditions:
ADHD
Eligibility:
All Genders
14-17 years
Phase:
NA
Brief Summary
The primary aim of the present research project is to examine the feasibility, as measured by treatment perceptions, and tolerability, as measured by adherence and attrition, of two weeks of flashed l...
Detailed Description
Participation in this research will last about 7 weeks. Participation will involve an initial screening visit lasting 3 hours to assess eligibility. This visit will involve interviews and tasks to ass...
Eligibility Criteria
Inclusion
- Age of 14 to 17 years
- Current DSM-5 diagnosis of attention-deficit/hyperactivity disorder (any type)
- Self-reported average bedtime of 11:00 pm or later, with difficulty shifting bedtime earlier and difficulty waking up early enough in the morning
- Evening chronotype (i.e., score ≤ 27 on the Morningness-Eveningness scale for Children)
- Clinically significant ADHD severity (ADHD-Rating Scale-5 score ≥ 24)
- Moderate global functioning impairment or worse (Clinical Global Impression-Severity scale score ≥ 4)
- Attending school (i.e., standard school year or summer school) during study enrollment
- Fluency in English
Exclusion
- Current or lifetime diagnosis of bipolar Disorder, psychosis, autism spectrum disorder, or pervasive developmental disorder
- Alcohol or substance dependence or suicidality within the past 6 months
- Current depression or anxiety in the severe range or higher
- Sleep disorder present besides delayed sleep-wake phase disorder (Clinical Sleep History Interview)
- Sleep solely in the prone position (i.e., on stomach)
- Full scale IQ ≤ 80 (Wechsler Abbreviated Scale for Intelligence-II)
- Use of any over-the-counter (e.g., melatonin, Benadryl) or prescribed sleep medication in the past month or planned use during the study
- Changes to any psychiatric medication within one month of study enrollment or planned changes during the study
- Use of photosensitizing medication within one month of study enrollment or planned during the study
- Participation in behavior therapy for sleep and/or ADHD within 3 months of study enrollment or planned participation during the course of the study
- Use of light therapy within 6 months of study enrollment or planned use during the study
- Travel across \> 2 time zones within one month of study enrollment or planned travel outside of the time zone of participation during the study
- Structural barriers to sleep (e.g., night shift work, extracurriculars scheduled until late in the evening, early rising for sports practice)
- Medical or neurological condition (e.g., seizure disorder, chronic migraines) that would interfere in the individual's ability to participate
Key Trial Info
Start Date :
October 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06036420
Start Date
October 20 2023
End Date
June 20 2025
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
Los Angeles, California, United States, 90095